Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727).

Clin Cancer Res · 2023 · PMC10502473 · PMID 37574209

Europe PMC DOI

hedged sentence

0.1950

closest p · 3.9× alpha

0.1950

boldest claim

The sentences

did not reach statistical significanceP = 0.195not close (p > 0.1)

The RPS signature measure tended to decrease, although this did not reach statistical significance (mean change = 0.51; P = 0.195; Supplementary Table S3; Fig. 4A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.